124 related articles for article (PubMed ID: 17036144)
1. MAGfect: a novel liposome formulation for MRI labelling and visualization of cells.
Oliver M; Ahmad A; Kamaly N; Perouzel E; Caussin A; Keller M; Herlihy A; Bell J; Miller AD; Jorgensen MR
Org Biomol Chem; 2006 Sep; 4(18):3489-97. PubMed ID: 17036144
[TBL] [Abstract][Full Text] [Related]
2. Bimodal paramagnetic and fluorescent liposomes for cellular and tumor magnetic resonance imaging.
Kamaly N; Kalber T; Ahmad A; Oliver MH; So PW; Herlihy AH; Bell JD; Jorgensen MR; Miller AD
Bioconjug Chem; 2008 Jan; 19(1):118-29. PubMed ID: 17985841
[TBL] [Abstract][Full Text] [Related]
3. Cationic Gd-DTPA liposomes for highly efficient labeling of mesenchymal stem cells and cell tracking with MRI.
Guenoun J; Koning GA; Doeswijk G; Bosman L; Wielopolski PA; Krestin GP; Bernsen MR
Cell Transplant; 2012; 21(1):191-205. PubMed ID: 21929868
[TBL] [Abstract][Full Text] [Related]
4. Stabilized porous liposomes with encapsulated Gd-labeled dextran as a highly efficient MRI contrast agent.
Cheng Z; Al Zaki A; Jones IW; Hall HK; Aspinwall CA; Tsourkas A
Chem Commun (Camb); 2014 Mar; 50(19):2502-4. PubMed ID: 24457826
[TBL] [Abstract][Full Text] [Related]
5. Analysis of feasibility of in vitro nuclear magnetic resonance tracking human umbilical cord mesenchymal stem cells by Gd-DTPA labeled.
Shuai HL; Yan RL; Song H; Chen DL; Luo X
Magn Reson Imaging; 2014 Sep; 32(7):934-40. PubMed ID: 24794127
[TBL] [Abstract][Full Text] [Related]
6. Cell-assembled nanoclusters of MSC-targeting Gd-DOTA-peptide as a T
Zhang P; Zhang Y; Li B; Zhang H; Lin H; Deng Z; Tan B
J Pept Sci; 2018 Jun; 24(4-5):e3077. PubMed ID: 29582508
[TBL] [Abstract][Full Text] [Related]
7. MRI-visible liposome nanovehicles for potential tumor-targeted delivery of multimodal therapies.
Ren L; Chen S; Li H; Zhang Z; Ye C; Liu M; Zhou X
Nanoscale; 2015 Aug; 7(30):12843-50. PubMed ID: 26022345
[TBL] [Abstract][Full Text] [Related]
8. Gadolinium chelate with DO3A conjugated 2-(diphenylphosphoryl)-ethyldiphenylphosphonium cation as potential tumor-selective MRI contrast agent.
Chandrasekharan P; Yong CX; Poh Z; He T; He Z; Liu S; Robins EG; Chuang KH; Yang CT
Biomaterials; 2012 Dec; 33(36):9225-31. PubMed ID: 23026708
[TBL] [Abstract][Full Text] [Related]
9. Paramagnetic liposomes as magnetic resonance imaging contrast agents. Assessment of contrast efficacy in various liver models.
Fossheim SL; Colet JM; Månsson S; Fahlvik AK; Muller RN; Klaveness J
Invest Radiol; 1998 Nov; 33(11):810-21. PubMed ID: 9818315
[TBL] [Abstract][Full Text] [Related]
10. Thermodynamic aspects and biological profile of CDAN/DOPE and DC-Chol/DOPE lipoplexes.
Keller M; Jorgensen MR; Perouzel E; Miller AD
Biochemistry; 2003 May; 42(20):6067-77. PubMed ID: 12755608
[TBL] [Abstract][Full Text] [Related]
11. A low molecular weight folate receptor targeted contrast agent for magnetic resonance tumor imaging.
Kalber TL; Kamaly N; So PW; Pugh JA; Bunch J; McLeod CW; Jorgensen MR; Miller AD; Bell JD
Mol Imaging Biol; 2011 Aug; 13(4):653-62. PubMed ID: 20809208
[TBL] [Abstract][Full Text] [Related]
12. Novel dual labelled nucleus-directed conjugates containing correct and mutant nuclear localisation sequences.
Sturzu A; Regenbogen M; Klose U; Echner H; Gharabaghi A; Heckl S
Eur J Pharm Sci; 2008 Mar; 33(3):207-16. PubMed ID: 18243673
[TBL] [Abstract][Full Text] [Related]
13. Paramagnetic liposomes as MRI contrast agents: influence of liposomal physicochemical properties on the in vitro relaxivity.
Fossheim SL; Fahlvik AK; Klaveness J; Muller RN
Magn Reson Imaging; 1999 Jan; 17(1):83-9. PubMed ID: 9888401
[TBL] [Abstract][Full Text] [Related]
14. Mannan-coated liposome delivery of gadolinium-diethylenetriaminepentaacetic acid, a contrast agent for use in magnetic resonance imaging.
Kunimasa J; Inui K; Hori R; Kawamura Y; Endo K
Chem Pharm Bull (Tokyo); 1992 Sep; 40(9):2565-7. PubMed ID: 1446380
[TBL] [Abstract][Full Text] [Related]
15. A high relaxivity Gd(III)DOTA-DSPE-based liposomal contrast agent for magnetic resonance imaging.
Hak S; Sanders HM; Agrawal P; Langereis S; Grüll H; Keizer HM; Arena F; Terreno E; Strijkers GJ; Nicolay K
Eur J Pharm Biopharm; 2009 Jun; 72(2):397-404. PubMed ID: 18940253
[TBL] [Abstract][Full Text] [Related]
16. A novel cationic cholesterol derivative, its formulation into liposomes, and the efficient transfection of the transformed human cell lines HepG2 and HeLa.
Kisoon N; Ariatti M; Moodley T
Drug Deliv; 2002; 9(3):161-7. PubMed ID: 12396733
[TBL] [Abstract][Full Text] [Related]
17. Multimodal targeted high relaxivity thermosensitive liposome for in vivo imaging.
Kuijten MM; Hannah Degeling M; Chen JW; Wojtkiewicz G; Waterman P; Weissleder R; Azzi J; Nicolay K; Tannous BA
Sci Rep; 2015 Nov; 5():17220. PubMed ID: 26610702
[TBL] [Abstract][Full Text] [Related]
18. Structure-transfection activity relationships in a series of novel cationic lipids with heterocyclic head-groups.
Ivanova EA; Maslov MA; Kabilova TO; Puchkov PA; Alekseeva AS; Boldyrev IA; Vlassov VV; Serebrennikova GA; Morozova NG; Zenkova MA
Org Biomol Chem; 2013 Nov; 11(41):7164-78. PubMed ID: 24057052
[TBL] [Abstract][Full Text] [Related]
19. S4(13)-PV cell penetrating peptide and cationic liposomes act synergistically to mediate intracellular delivery of plasmid DNA.
Trabulo S; Mano M; Faneca H; Cardoso AL; Duarte S; Henriques A; Paiva A; Gomes P; Simões S; de Lima MC
J Gene Med; 2008 Nov; 10(11):1210-22. PubMed ID: 18729238
[TBL] [Abstract][Full Text] [Related]
20. Gadolinium-conjugated TiO2-DNA oligonucleotide nanoconjugates show prolonged intracellular retention period and T1-weighted contrast enhancement in magnetic resonance images.
Paunesku T; Ke T; Dharmakumar R; Mascheri N; Wu A; Lai B; Vogt S; Maser J; Thurn K; Szolc-Kowalska B; Larson A; Bergan RC; Omary R; Li D; Lu ZR; Woloschak GE
Nanomedicine; 2008 Sep; 4(3):201-7. PubMed ID: 18567541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
